Prevalence, risk factors and mortality of pulmonary hypertension defined by right heart catheterization in patients with sickle cell disease

Expert Review of Hematology

Volumn 4, Issue 6, 2011, Pages 593-596

  Gladwin, Mark T ^a,b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

hemoglobin; hemolytic anemia; nitric oxide; pulmonary hypertension; right heart catheterization; sickle cell disease; sudden death

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE;

ACUTE CHEST SYNDROME; ARTICLE; DOPPLER ECHOGRAPHY; EXERCISE; HEART CATHETERIZATION; HEMOLYSIS; HEMOLYTIC ANEMIA; HUMAN; KIDNEY FAILURE; LEG ULCER; LUNG ARTERY PRESSURE; PREVALENCE; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RISK FACTOR; SICKLE CELL ANEMIA;

ANEMIA, SICKLE CELL; FEMALE; HEMODYNAMICS; HUMANS; HYPERTENSION, PULMONARY; MALE;

EID: 81255197577     PISSN: 17474086     EISSN: 17474094     Source Type: Journal    
DOI: 10.1586/ehm.11.66     Document Type: Article

References (21)

1. Gladwin MT, Sachdev V, Jison ML et al. Pulmonary hypertension as a risk factor for death in patients with sickle cell disease. N. Engl. J. Med. 350(9), 886-895 (2004). (Pubitemid 38252536)
2. Sachdev V, Kato GJ, Gibbs JS et al. Echocardiographic markers of elevated pulmonary pressure and left ventricular diastolic dysfunction are associated with exercise intolerance in adults and adolescents with homozygous sickle cell anemia in the United States and United Kingdom. Circulation 124(13), 1452-1460 (2011).
3. Sachdev V, Machado RF, Shizukuda Y et al. Diastolic dysfunction is an independent risk factor for death in patients with sickle cell disease. J. Am. Coll. Cardiol. 49(4), 472-479 (2007). (Pubitemid 46135890)
4. Machado RF, Anthi A, Steinberg MH et al. N-terminal pro-brain natriuretic peptide levels and risk of death in sickle cell disease. JAMA 296(3), 310-318 (2006). (Pubitemid 44079315)
5. Machado RF, Hildescheim M, Mendelsohn L, Kato GJ, Gladwin MT. NT-pro brain natriuretic peptide levels and the risk of stroke and death in the cooperative study of sickle cell disease. Blood 114, 1541 (2009).
6. Ataga KI, Moore CG, Jones S et al. Pulmonary hypertension in patients with sickle cell disease: A longitudinal study. Br. J. Haematol. 134(1), 109-115 (2006). (Pubitemid 43830036)
7. De Castro LM, Jonassaint JC, Graham FL, Ashley-Koch A, Telen MJ. Pulmonary hypertension associated with sickle cell disease: clinical and laboratory endpoints and disease outcomes. Am. J. Hematol. 83(1), 19-25 (2008).
8. Gladwin MT, Vichinsky E. Pulmonary complications of sickle cell disease. N. Engl. J. Med. 359(21), 2254-2265 (2008).
9. Reiter CD, Wang X, Tanus-Santos JE et al. Cell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease. Nat. Med. 8(12), 1383-1389 (2002). (Pubitemid 36019423)
10. Rother RP, Bell L, Hillmen P, Gladwin MT. The clinical sequelae of intravascular hemolysis and extracellular plasma hemoglobin: A novel mechanism of human disease. JAMA 293(13), 1653-1662 (2005). (Pubitemid 40471796)
11. Morris CR, Kato GJ, Poljakovic M et al. Dysregulated arginine metabolism, hemolysis-associated pulmonary hypertension, and mortality in sickle cell disease. JAMA 294(1), 81-90 (2005). (Pubitemid 41002842)
12. Donadee C, Raat NJ, Kanias T et al. Nitric oxide scavenging by red blood cell microparticles and cell-free hemoglobin as a mechanism for the red cell storage lesion. Circulation 124(4), 465-476 (2011).
13. Bunn HF, Nathan DG, Dover GJ et al. Pulmonary hypertension and nitric oxide depletion in sickle cell disease. Blood 116(5), 687-692 (2010).
14. Hebbel RP. Reconstructing sickle cell disease: A data-based analysis of the hyperhemolysis paradigm for pulmonary hypertension from the perspective of evidence-based medicine. Am. J. Hematol. 86(2), 123-154 (2011).
15. Parent F, Bachir D, Inamo J et al. A hemodynamic study of pulmonary hypertension in sickle cell disease. N. Engl. J. Med. 365(1), 44-53 (2011).
16. Fonseca GH, Souza R, Salemi VM, Jardim CV, Gualandro SF. Pulmonary hypertension diagnosed by right heart catheterization in sickle cell disease. Eur. Respir. J. doi:10.1183/09031936.00134410 (2011) (Epub ahead of print).
17. Rees DC, Williams TN, Gladwin MT. Sickle-cell disease. Lancet 376(9757), 2018-2031 (2010).
18. Hachulla E, Gressin V, Guillevin L et al. Early detection of pulmonary arterial hypertension in systemic sclerosis: A French nationwide prospective multicenter study. Arthritis Rheum. 52(12), 3792-3800 (2005). (Pubitemid 41798217)
19. Anthi A, Machado RF, Jison ML et al. Hemodynamic and functional assessment of patients with sickle cell disease and pulmonary hypertension. Am. J. Respir. Crit. Care Med. 175(12), 1272-1279 (2007). (Pubitemid 46905753)
20. Kovacs G, Berghold A, Scheidl S, Olschewski H. Pulmonary arterial pressure during rest and exercise in healthy subjects: A systematic review. Eur. Respir. J. 34(4), 888-894 (2009).
21. Kovacs G, Maier R, Aberer E et al. Borderline pulmonary arterial pressure is associated with decreased exercise capacity in scleroderma. Am. J. Respir. Crit. Care Med. 180(9), 881-886 (2009).